EP Patent

EP4268814A3 — Pharmaceutical composition for the treatment of dry eye

Assigned to Consejo Superior de Investigaciones Cientificas CSIC · Expires 2024-01-24 · 2y expired

What this patent protects

The invention relates to therapeutic compositions for the treatment of dry eye, more specifically to compositions comprising a TRPM8 receptor agonist ligand. Furthermore, the invention relates to therapeutic compositions for the treatment of epiphora, more specifically to composi…

USPTO Abstract

The invention relates to therapeutic compositions for the treatment of dry eye, more specifically to compositions comprising a TRPM8 receptor agonist ligand. Furthermore, the invention relates to therapeutic compositions for the treatment of epiphora, more specifically to compositions comprising a TRPM8 receptor antagonist.

Drugs covered by this patent

Patent Metadata

Patent number
EP4268814A3
Jurisdiction
EP
Classification
—
Expires
2024-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.